Doctors should inform patients to be alert to any mood changes, distressing thoughts, or feelings about suicide or self-harm when prescribing fluoroquinolone antibiotics.
Given that October is filled with awareness days focused on health literacy and mental well being, we wanted to take a moment to again share our annual highlights and thank you for your support. Together, we are saving lives.
It’s great to see Dr. Josef Witt-Doerring, a Board Certified Psychiatrist, former FDA Officer and drug-tapering expert highlighting akathisia. “Everyone needs to know the word akathisia,” says Witt-Doerring. Listen and learn at https://x.com/wdpsychiatry/status/1714739709015212519?s=20.
When it comes to drug-induced problems ”like protracted withdrawal, PSSD, or drug induced akathisia, which we have known about for 7 decades but still don’t understand, for instance, it’s difficult to see how there can be experts.” — Dr. David Healy
In the case of akathisia in particular, groups like MISSD are doing extraordinary work explaining the problem, offering helpful suggestions and raising the profile of a problem that takes so many lives you’d have thought we be working all out to make sure people knew about it. MISSD are doing the kind of work you’d figure the experts or professionals in psychiatric associations like the Royal College of APA should be doing but aren’t. Read the full article at https://rxisk.org/treatment-complications-good-expert-needed/.
October is Health Literacy Month and a good opportunity for healthcare professionals and consumers to learn more about akathisia and medications that can cause self-harm, violence, and suicide. See our educational resources at MISSD.co and take our free accredited course at http://MISSD.LearnUpon.com. Knowing the causes and symptoms of akathisia can save lives.